Susanna Harju-Baker

3.0k total citations · 2 hit papers
19 papers, 2.1k citations indexed

About

Susanna Harju-Baker is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Susanna Harju-Baker has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Susanna Harju-Baker's work include Sepsis Diagnosis and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Genomics and Chromatin Dynamics (3 papers). Susanna Harju-Baker is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Genomics and Chromatin Dynamics (3 papers). Susanna Harju-Baker collaborates with scholars based in United States, Canada and United Kingdom. Susanna Harju-Baker's co-authors include David G. Maloney, Kevin A. Hay, Stanley R. Riddell, Juliane Gust, Laïla‐Aïcha Hanafi, Cameron J. Turtle, Daniel Li, Dominic W. Chung, Junmei Chen and José A. López and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Susanna Harju-Baker

19 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

2017 948 citations Juliane Gust, Kevin A. Hay et al. Cancer Discovery profile →
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

2017 775 citations Kevin A. Hay, Laïla‐Aïcha Hanafi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susanna Harju-Baker United States	13	1.6k	525	432	420	398	19	2.1k
Cecilia C.S. Yeung United States	18	1.3k 0.8×	377 0.7×	392 0.9×	317 0.8×	365 0.9×	81	2.0k
Daniel Li United States	15	2.8k 1.8×	863 1.6×	748 1.7×	814 1.9×	614 1.5×	24	3.3k
Judith Feucht Germany	17	1.2k 0.8×	333 0.6×	719 1.7×	304 0.7×	820 2.1×	39	2.4k
Tahsin Özpolat United States	7	850 0.5×	306 0.6×	193 0.4×	210 0.5×	185 0.5×	25	1.1k
Jinjuan Wang China	12	1.6k 1.0×	508 1.0×	462 1.1×	557 1.3×	657 1.7×	32	1.8k
Patrick M. Reagan United States	19	949 0.6×	144 0.3×	258 0.6×	205 0.5×	366 0.9×	83	1.3k
Tobias Neff United States	28	419 0.3×	239 0.5×	1.7k 4.0×	544 1.3×	219 0.6×	64	2.5k
Swati Naik United States	16	561 0.3×	125 0.2×	238 0.6×	256 0.6×	272 0.7×	90	1.0k
Francesca Del Bufalo Italy	20	478 0.3×	163 0.3×	330 0.8×	182 0.4×	269 0.7×	78	1.2k
Li Gao China	20	617 0.4×	172 0.3×	359 0.8×	159 0.4×	341 0.9×	87	1.4k

Countries citing papers authored by Susanna Harju-Baker

Since Specialization

Citations

This map shows the geographic impact of Susanna Harju-Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Harju-Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Harju-Baker more than expected).

Fields of papers citing papers by Susanna Harju-Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Harju-Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Harju-Baker. The network helps show where Susanna Harju-Baker may publish in the future.

Co-authorship network of co-authors of Susanna Harju-Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Harju-Baker. A scholar is included among the top collaborators of Susanna Harju-Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Harju-Baker. Susanna Harju-Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Debrand, Emmanuel, Lyubomira Chakalova, Yanfeng Dai, et al.. (2019). An intergenic non-coding RNA promoter required for histone modifications in the human β-globin chromatin domain. PLoS ONE. 14(8). e0217532–e0217532. 3 indexed citations

Melendez, Elliot, Jane Whitney, Melanie Silverman, et al.. (2019). Systemic Angiopoietin-1/2 Dysregulation in Pediatric Sepsis and Septic Shock. International Journal of Medical Sciences. 16(2). 318–323. 13 indexed citations

Gust, Juliane, Kevin A. Hay, Laïla‐Aïcha Hanafi, et al.. (2017). Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells. Cancer Discovery. 7(12). 1404–1419. 948 indexed citations breakdown →

Mikacenic, Carmen, Brenda Price, Susanna Harju-Baker, et al.. (2017). A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis. American Journal of Respiratory and Critical Care Medicine. 196(8). 1004–1011. 46 indexed citations

Bhatraju, Pavan K., Cassianne Robinson‐Cohen, Carmen Mikacenic, et al.. (2017). Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype. Critical Care. 21(1). 217–217. 18 indexed citations

Morrell, Eric D., D. Shane O’Mahony, Bradford J. Glavan, et al.. (2017). Genetic Variation in MAP3K1 Associates with Ventilator-Free Days in Acute Respiratory Distress Syndrome. American Journal of Respiratory Cell and Molecular Biology. 58(1). 117–125. 16 indexed citations

Turtle, Cameron J., Kevin A. Hay, Laïla‐Aïcha Hanafi, et al.. (2017). Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy. Blood. 130(Suppl_1). 805–805. 2 indexed citations

Turtle, Cameron J., Kevin A. Hay, Juliane Gust, et al.. (2017). Cytokine release syndrome (CRS) and neurotoxicity (NT) after CD19-specific chimeric antigen receptor- (CAR-) modified T cells.. Journal of Clinical Oncology. 35(15_suppl). 3020–3020. 15 indexed citations

Hay, Kevin A., Laïla‐Aïcha Hanafi, Daniel Li, et al.. (2017). Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy. Blood. 130(21). 2295–2306. 775 indexed citations breakdown →

10.

Hahn, Won-Ho, Susanna Harju-Baker, Laura K. Erdman, et al.. (2016). A common TLR1 polymorphism is associated with higher parasitaemia in a Southeast Asian population with Plasmodium falciparum malaria. Malaria Journal. 15(1). 12–12. 16 indexed citations

11.

Robinson‐Cohen, Cassianne, Ronit Katz, Brenda Price, et al.. (2016). Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients. Critical Care. 20(1). 207–207. 39 indexed citations

12.

Mikacenic, Carmen, Brenda Price, Susanna Harju-Baker, et al.. (2016). 1372: DEVELOPMENT OF A ROBUST BIOMARKER PREDICTIVE MODEL FOR DEATH IN ICU PATIENTS WITH SIRS AND SEPSIS. Critical Care Medicine. 44(12). 418–418. 1 indexed citations

13.

Mikacenic, Carmen, Won-Ho Hahn, Brenda Price, et al.. (2015). Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness. PLoS ONE. 10(10). e0141251–e0141251. 78 indexed citations

14.

Glavan, Bradford J., et al.. (2012). A Common Non-Synonymous Coding SNP In MEKK1 Increases AP1 Transcription Activity And Is Associated With Mortality In ALI. A1967–A1967. 1 indexed citations

15.

Peterson, Kenneth R., Halyna Fedosyuk, & Susanna Harju-Baker. (2012). LCR 5′ hypersensitive site specificity for globin gene activation within the active chromatin hub. Nucleic Acids Research. 40(22). 11256–11269. 6 indexed citations

16.

McGuire, John K., et al.. (2012). Matrilysin (MMP-7) Inhibition of BMP-7 Induced Renal Tubular Branching Morphogenesis Suggests a Role in the Pathogenesis of Human Renal Dysplasia. Journal of Histochemistry & Cytochemistry. 60(3). 243–253. 5 indexed citations

17.

Manicone, Anne M., et al.. (2011). Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival. Respiratory Research. 12(1). 144–144. 15 indexed citations

18.

Harju-Baker, Susanna, et al.. (2009). Control of Promatrilysin (MMP7) Activation and Substrate-specific Activity by Sulfated Glycosaminoglycans. Journal of Biological Chemistry. 284(41). 27924–27932. 57 indexed citations

19.

Harju-Baker, Susanna, et al.. (2008). Silencing of ^A γ-Globin Gene Expression during Adult Definitive Erythropoiesis Mediated by GATA-1-FOG-1-Mi2 Complex Binding at the −566 GATA Site. Molecular and Cellular Biology. 28(10). 3101–3113. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact